Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The intermediate CCU admission: a preliminary study.

J E Calvin1, L Klein, E VandenBerg

  • 1Section of Critical Care Medicine, Section of Cardiology, Rush-Presbyterian-St. Luke's Medical Center, Chicago, Illinois, USA. jcalvin@rpslmc.edu

Heart Disease (Hagerstown, Md.)
|April 27, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Microbiology, time course and clinical characteristics of infection in critically ill patients receiving packed red blood cell transfusion.

Vox sanguinis·2009
Same author

Image-based monitoring of one-lung ventilation.

European journal of anaesthesiology·2008
Same author

Outcome of bone marrow transplantation in acquired and inherited aplastic anaemia in the Republic of Ireland.

Irish journal of medical science·2005
Same author

Introducing a new editor for Pediatric Critical Care Medicine: Patrick M. Kochanek, MD.

Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies·2003
Same author

Pediatric Critical Care Medicine: Another member of the critical care family.

Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies·2003
Same author

Probable Kawasaki disease in a 52-year-old man presenting with acute myocardial infarction treated with percutaneous revascularization.

Heart disease (Hagerstown, Md.)·2002
Same journal

Ximelagatran: a new oral anticoagulant.

Heart disease (Hagerstown, Md.)·2003
Same journal

Long-term (2-4 year) weight reduction with metformin plus carbohydrate-modified diet in euglycemic, hyperinsulinemic, midlife women (Syndrome W).

Heart disease (Hagerstown, Md.)·2003
Same journal

A comparison of humanistic qualities among medical students, residents, and faculty physicians in internal medicine.

Heart disease (Hagerstown, Md.)·2003
Same journal

Effect of carotid angioplasty-stenting on short-term mortality and stroke.

Heart disease (Hagerstown, Md.)·2003
Same journal

Evidence for the extrapulmonary localization of inhaled nitric oxide.

Heart disease (Hagerstown, Md.)·2003
Same journal

Timing and duration of administration are crucial for antiinfarct effect of AMP 579 infused at reperfusion in rabbit heart.

Heart disease (Hagerstown, Md.)·2003
See all related articles

Intermediate-risk cardiac patients can be safely treated in an intermediate coronary care unit (ICCU) at a lower cost than in a standard coronary care unit (CCU). This approach supports cost reduction without compromising patient safety or outcomes.

Area of Science:

  • Cardiology
  • Health Economics
  • Healthcare Management

Background:

  • Increasing emphasis on cost reduction in healthcare.
  • Agency for Healthcare Policy and Research (AHCPR) guidelines suggest intermediate-risk patients be admitted to an intermediate CCU (ICCU).
  • Limited prospective evaluation of ICCU safety and appropriateness for intermediate-risk patients.

Purpose of the Study:

  • To hypothesize that admitting intermediate-risk patients to an ICCU is cheaper than admitting to a CCU with comparable safety.
  • To evaluate the safety and cost-effectiveness of admitting intermediate-risk patients to an ICCU versus a CCU.

Main Methods:

  • Retrospective cohort study comparing 243 intermediate-risk patients.
  • Patients admitted to CCU (n=134) and ICCU (n=109) between June 1992 and April 1994.

Related Experiment Videos

  • Utilized AHCPR definitions for intermediate risk and a risk prediction model; collected demographic, clinical, diagnostic, treatment, and outcome data.

    • Main Results:

    • Groups were similar in baseline characteristics, including age, sex, comorbidities (diabetes, previous MI, previous surgery), and presenting symptoms.
    • Rates of coronary angiography, angioplasty, and coronary artery surgery were comparable between CCU and ICCU groups.
    • Incidence of myocardial infarction or death was similar (3% vs 5%), length of stay was similar (6.7 vs 6.5 days), but cost was significantly lower for ICCU ($10,619 vs $13,481, P < 0.015).

    Conclusions:

    • Intermediate-risk patients, identified by AHCPR guidelines, can be treated in an ICCU at a lower cost than in a CCU with reasonable safety.
    • Admission to ICCU does not impede recommended patient evaluation and management.
    • Requires availability of cardiac resuscitation and monitoring for potential myocardial infarction in ICCU patients.